🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Corneal Dystrophy

OCT in Fuchs' Dystrophy NCT04258787n/a1 site📍 Portland Oregon Health and Science University Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy NCT04440280Phase 21 site📍 Boston Massachusetts Eye and Ear Infirmary · Tests: N-acetyl cysteine (NAC) 10% solution, N-acetyl cysteine (NAC) 20% solution, Visine Dry Eye Relief eye drops The OPTIMISE Study NCT05716945Phase 48 sites📍 Apeldoorn📍 Nijmegen📍 Maastricht Maastricht University Medical Center · Tests: Fluorometholone 0.1% Oph Susp, Dexamethasone 0.1% ophthalmic suspension, Stop steroids Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy NCT01243931NA1 site📍 Portland Oregon Health and Science University · Tests: OCT-guided laser phototherapeutic keratectomy OCT in Diagnosis of Irregular Corneas NCT03504800n/a1 site📍 Portland Oregon Health and Science University · Tests: Optical Coherence Tomography Nephrotic Syndrome Study Network NCT01209000n/a44 sites📍 Los Angeles📍 Palo Alto📍 San Francisco University of Michigan · Tests: Kidney Biopsy Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease NCT05650619n/a1 site📍 Ann Arbor University of Michigan · Tests: Biospecimen collection, Data collection An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases NCT06664814Phase 21 site📍 Bethesda National Human Genome Research Institute (NHGRI) · Tests: ManNAc Study to Assess Safety and Tolerability of Multiple Doses of EO2002 NCT05636579Phase 11 site📍 Mexico City Asociación para Evitar la Ceguera en México · Tests: EO2002, Ripasudil Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health Simple Non-cultured Endothelial Cell Therapy for Corneal Endothelial Dysfunction NCT07711561Phase 11 site📍 Hyderabad Singapore Eye Research Institute · Tests: Cell injection Analysis of the Genotype/Phenotype Relationship in the Fuchs' Corneal Endothelial Dystrophy in France NCT05742321n/a1 site📍 Saint-Etienne Centre Hospitalier Universitaire de Saint Etienne · Tests: Genotyping, Histology, Collection of data Prognosis of Posterior Lamellar Keratoplasty NCT06859411n/a1 site📍 Metz Centre Hospitalier Régional Metz-Thionville · Tests: visual acuity comparaison SUCCESS Score Validation in Fuchs Dystrophy NCT07265388n/a1 site📍 Madrid Instituto Ramón y Cajal de Investigación Sanitaria · Tests: Phacoemulsification Cataract Surgery International Registry for Patients With Castleman Disease NCT02817997n/a1 site📍 Philadelphia University of Pennsylvania Plasma Rich in Growth Factors in Corneal Endothelial Transplantation NCT06261346NA2 sites📍 Miami📍 Indianapolis University of Miami · Tests: Endothelial keratoplasty, PRGF The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry) NCT03949972n/a12 sites📍 Cologne📍 Aachen📍 Berlin Prof. Dr. Paul Brinkkoetter · Tests: Biosampling Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty NCT04319848Phase 11 site📍 Singapore Singapore Eye Research Institute · Tests: TE-EK treatment group Descemet Endothelial Thickness Comparison Trial II NCT05275972Phase 38 sites📍 Palo Alto📍 Sacramento📍 Palm Beach Gardens Stanford University · Tests: Ripasudil, Placebo DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy NCT07024693Phase 22 sites📍 Indianapolis📍 Grand Rapids Design Therapeutics, Inc. · Tests: DT-168 The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery NCT06048380Phase 31 site📍 Singapore Singapore Eye Research Institute · Tests: Ripasudil, Placebo High Resolution, High-speed Multimodal Ophthalmic Imaging NCT04129021NA1 site📍 Paris Centre Hospitalier National d'Ophtalmologie des Quinze-Ving… · Tests: High-resolution retinal imaging through adaptive optics, High-resolution retinal imaging through holographic systems A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia NCT02118922n/a1 site📍 Boston Massachusetts General Hospital · Tests: Brillouin imaging Glanatec(R) for Descemet Stripping in Fuch's Endothelial Dystrophy NCT03249337Phase 41 site📍 Glenview Marian Macsai, MD · Tests: Ripasudil hydrochloride hydrate 0.4% ophthalmic solution Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases NCT05003986Phase 247 sites📍 Los Angeles📍 Wilmington📍 Miami Travere Therapeutics, Inc. · Tests: Sparsentan, Sparsentan, Sparsentan FECD-TRACE: Fuchs' Endothelial Corneal Dystrophy TRAjectory and Correlation With Genotype in the United Kingdom NCT06881771n/a1 site📍 London University College, London · Tests: Clinical phenotyping, CTG18.1 Expansion Status Genotyping Effect of Descemet Membrane Polishing in Fuchs Endothelial Corneal Dystrophy NCT07539012NA5 sites📍 Saint-Etienne📍 Metz📍 Paris Centre Hospitalier Universitaire de Saint Etienne · Tests: Fuchs Polishing National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases NCT06491615n/a2 sites📍 Bethesda📍 Bethesda National Eye Institute (NEI) Atacicept in Multiple Glomerular Diseases NCT06983028Phase 21 site📍 Brisbane Vera Therapeutics, Inc. · Tests: Atacicept NEPTUNE Match Study NCT04571658NA16 sites📍 Atlanta📍 Chicago📍 Kansas City University of Michigan · Tests: Communication
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy